Australia's largest stock trading and investment forum Australia's #1 stock forum

IMU

Click for more information

0.00%

29.0¢

IMUGENE LIMITED

Market Cap $1.701B Add to my watchlist

ASX CANNABIS LEADER

Althea Group (ASX:AGH) stellar Q4 performance sees FY22 cash receipts up 130% to $22m.

Latest Threads

Tag

Subject

CEO Exclusive - IMU doses first patient in phase one trial

2

24/07/22

105

115K

24/07/22

Last post kierancrowe

105

115K

Why IMU is a multi multi bagger

139 140 141

06:51

8.4K

4.1M

06:51

Last post Footmax

8.4K

4.1M

Media Thread

105 106 107

15/08/22

6.3K

2.9M

15/08/22

Last post Glouva

6.3K

2.9M

IMU to hit 4c today??!!!!

15/08/22

49

18K

15/08/22

Last post cane7

49

18K

Ann: BPAY or EFT Process for IMUOC & IMUOD Option Holders

15/08/22

35

19K

15/08/22

Last post Hammer_time

35

19K

IMUGENE CHART. TA only

295 296 297

15/08/22

17K

8.2M

15/08/22

Last post mcgaffen

17K

8.2M

Ann: FIRST COHORT 3 PATIENT DOSED IN CLINICAL TRIAL OF CHECKVACC

2

13/08/22

75

35K

13/08/22

Last post Digger59

75

35K

Ann: Final HER-Vaxx Phase 2 Trial Overall Survival Results

5 6 7

12/08/22

383

170K

12/08/22

Last post fattchoi

383

170K

Ann: Research partnership with Celularity for solid tumors

2 3

11/08/22

177

75K

11/08/22

Last post radar9010

177

75K

See All Discussions

Timeline

FIRST COHORT 3 PATIENT DOSED IN CLINICAL TRIAL OF CHECKVACC
10 Aug 09:18	Share

Imugene Presents New PD1-Vaxx Data at the 2022 WCLC
08 Aug 09:06	Share

Application for quotation of securities - IMU
05 Aug 16:32	Share

Quarterly Activities/Appendix 4C Cash Flow Report
25 Jul 11:27	Share

Notification regarding unquoted securities - IMU
21 Jul 16:48	Share

Application for quotation of securities - IMU
21 Jul 16:36	Share

Imugene appoints experienced life sciences CFO Mike Tonroe
18 Jul 09:35	Share

IMU to Present New PD1-Vaxx Data at the WCLC 2022
13 Jul 09:30	Share

Appointment of Dr Sharon Yavrom as Clinical Scientist
01 Jul 11:44	Share

Investor Webinar - Final HER-Vaxx Overall Survival Results
27 Jun 09:15	Share

Final HER-Vaxx Phase 2 Trial Overall Survival Results
27 Jun 08:24	Share

Change of Director's Interest Notice - CW
14 Jun 09:10	Share

Change of Director's Interest Notice - LR
09 Jun 16:43	Share

Notice Under Section 708A
08 Jun 17:48	Share

Application for quotation of securities - IMU
08 Jun 17:43	Share

IMUGENE APPOINTS DR YANGHEE WOO TO SCIENTIFIC ADVISORY BOARD
01 Jun 09:37	Share

IMUGENE PUBLICATION OF CHECKVACC ABSTRACT AT ASCO 2022
31 May 10:15	Share

IMUGENE ANNOUNCES PUBLICATION OF ASCO 2022 PD1-VAXX ABSTRACT
27 May 13:01	Share

Letter to Shareholders
23 May 08:37	Share

IMUGENE DOSES FIRST PATIENT IN VAXINIA PHASE 1 TRIAL
18 May 08:22	Share

IMU RECEIVES ETHICS APPROVAL TO START HER-VAXX NextHERIZON
10 May 08:31	Share

Response to ASX Query
09 May 14:02	Share

Clarification Announcement
03 May 13:02	Share

Pause in Trading
03 May 10:01	Share

Termination of Supply Agreement
02 May 12:37	Share

Application for quotation of securities - IMU
29 Apr 14:44	Share

Quarterly Activities/Appendix 4C Cash Flow Report
22 Apr 14:23	Share

First Cohort 2 Patient Dosed in Clinical Trial of CHECKvacc
13 Apr 09:29	Share

Release of Securities from Escrow
12 Apr 10:35	Share

Application for quotation of securities - IMU
01 Apr 11:53	Share

(20min delay) Trade with IG
Last 29.0¢		Change 0.000(0.00%)		Mkt cap ! $1.701B

Open	High	Low	Value	Volume
30.0¢	30.0¢	28.5¢	$5.367M	18.38M

Buyers (Bids)

No.	Vol.	Price($)
5	203796	28.5¢

Sellers (Offers)

Price($)	Vol.	No.
29.0¢	611017	10

View Market Depth

No.	Vol.	Price($)
4	201796	0.285
30	1608439	0.280
28	1459764	0.275
40	987447	0.270
31	2400497	0.265

Price($)	Vol.	No.
0.290	561017	9
0.295	1026239	22
0.300	1578604	31
0.305	1660057	26
0.310	1320453	22

Last trade - 16.10pm 15/08/2022 (20 minute delay)

(live)
Last 28.8¢			Change 0.000 ( 0.03 %)
Open	High		Low	Volume
29.8¢	30.0¢		28.5¢	7739588
Last updated 15.59pm 15/08/2022 (live) ?

IMU (ASX) Chart